KDR and cancer: By enhancing the extracellular secretion of MMPs, VEGF and VEGFR-2 and their interactions with other plasma membrane proteins, EMMPRIN accelerates the degradation of the ECM and promotes the migration, invasion and metastasis of cancer cells [11]–[17].